Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Cellebrite DI Ltd. (CLBT) shareholders who lost money after the Company's Q2 2026 results and reduced full-year outlook have legal rights -- Levi & Korsinsky is investigating potential securities law violations....
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Cellebrite DI Ltd. shares dropped over 30% after the Company reported Q2 2026 revenue of approximately $131.1 million and cut its full-year 2026 ARR and revenue guidance -- SueWallSt notifies investors...
Cellebrite DI Ltd. (CLBT) shareholders lost money when the stock sold off more than 30% following the Company's Q2 2026 results -- Levi & Korsinsky is investigating the Company's disclosures concerning...
MILWAUKEE , Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Cellebrite (NASDAQ: CLBT). The investigation results from inaccurate statements Cellebrite...
Company Reports Second-Quarter 2026 Results ; Company Lowers Full-Year 2026 ARR and Revenue Outlook and Raises Adjusted EBITDA Target
Barchart Research What to Expect from CLBT Earnings CLBT Generated August 12, 2026 Current Price $15.25 EPS Estimate $$0.09 Consensus Rating Strong Buy Average Move 7.00% Cellebrite's Genesis AI Monetization...
Cellebrite DI (NASDAQ:CLBT) executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal authorization...
Cellebrite DI (NASDAQ:CLBT) executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial intelligence...